Home » Topics » Regulatory » Patents

Patents
RSS

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

Dec. 10, 1996

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Sugen reports antihyperproliferative agents

Dec. 10, 1996

Merck & Co. reveals new agents for BPH

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

VIP analogs and derivatives claimed for smooth muscle relaxation

Dec. 9, 1996

New thrombin inhibitors under study at Merck & Co.

Dec. 9, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...